People 65 years and older and those who are moderately or severely immunocompromised should receive a second dose of 2024-2025 COVID-19 vaccine six months after their first dose. See the CDC's updated guidance. More Info
The laboratory we utilize has clinical trial data that is publicly available. Furthermore, the State of Delaware Division of Public Health performed additional validation tests to ensure accuracy